Dubai International Pharmaceuticals & Technologies Conference and Exhibition
09 - 11 March 2021
Pharmacotherapy Updates I
11:00 - 11:45
|Acute kidney injury: Guide to diagnosis and management|
Dr. Manal Hassan Ibrahim Bashihab | Saudi Arabia
Dr. Manal Hassan Ibrahim Bashihab | Saudi ArabiaConsultant Clinical Pharmacist/Nephrology Pharmacotherapy SFDA Pharmacovigilance Regional Representative
Dr. Bashihab is a consultant Clinical Pharmacist at Security Forces Hospital Program–Riyadh (SFH-P). She is the Co-chairman of Guidelines and Protocol Committee, and a member in many committees in her institute. Dr. Bashihab recently completed the certification as a new Professional Medication Safety Officer, and are entitled to the CMSO Credential. Dr. Manal received a bachelor pharmaceutical sciences degree from King Saud University, KSA. She obtained the Saudi Specialty Certificate in Clinical Pharmacy Practice (PGY1) in 2008 and she practiced as a pediatric clinical pharmacist until 2012. Then, she continued to obtain a certificate of the Saudi board of Health specialties in Nephrology Pharmacotherapy in 2015 and she used to work as a nephrology clinical pharmacist. Dr. Bashihab previous experience has equipped her to hold the position of an acting supervisor of IV Pharmacy (2009-2010) then promoted as supervisor of IV-Room on 2010 -2012, and finally as the acute care clinical coordinator on 2012-2017. Currently, she has been appointed to fill a responsible position of a regional Representative of the Saudi-FDA Pharmacovigilance office, and a Liaison Safety officer. She established many projects in her institute and delivered many presentations over the years nationally and internationally. Ultimately, Dr. Bashihab is the co-author with Dr. Al-Obaida in an educational book under title of الموسوعة التثقيفية الدوائية, sponsored by Saudi pharmaceutical society.
11:45 - 12:30
|Recent updates and core elements of antimicrobial stewardship program strategies|
Dr. Zahra Hassan AL Qamariat | Saudi Arabia
Dr. Zahra Hassan AL Qamariat | Saudi ArabiaSenior Clinical Pharmacist Antimicrobial Stewardship Pharmacist, American Society of Infectious Disease
Dr Zahra AL Qamariat is a Senior Clinical Pharmacist graduated from the School of Pharmacy University of London with a Master degree in Clinical Pharmacy International Practice and Policy. Then, she joined the Saudi Ministry of health and has been working as Senior Clinical Pharmacist at Dammam Medical Complex mainly in Infectious Disease and Intensive Care and a supervisor for clinical pharmacy services. Recently, Dr Zahra is the Chairperson of Antimicrobial Stewardship Committee in Dammam Medical Complex since May 2019. Also, she is the Chairperson of Clinical Pharmacy Committee in Eastern Health and the Rapporteur of Antimicrobial Committee, Eastern Health, Saudi Arabia since January 2017. Dr AL Qamariat has successfully complete courses in research from Harvard Medical School and King Faisal Specialist Hospital and Research. She is certified antimicrobial stewardship pharmacist from the American Society of Infectious Disease Pharmacist, and Professional Infection Control and Prevention from the American university of Ras Al Khaimah. Certified Anticoagulation Therapy Pharmacist by University of Florida.
12:30 - 13:15
|Comparison of antibiotic recommendation for infective endocarditis guidelines|
Dr. Khalid O. Eljaaly, | Saudi Arabia
Dr. Khalid O. Eljaaly, | Saudi ArabiaAssistant Professor and Infectious Disease Pharmacist Faculty of Pharmacy, KAU Hospital
Khalid Eljaaly, Pharm.D., CAPPS, MS, BCPS, is an assistant professor and infectious disease in faculty of pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia, and an honorary fellow in the University of Arizona, Tucson, AZ, USA. He graduated with a PharmD degree from King Abdulaziz University. He completed his PGY1 pharmacy practice residency at SEMC, a Tuft-University affiliated hospital and his PGY2 infectious disease pharmacy residency at BIDMC, a Harvard Medical School-affiliated hospital in Boston, MA, USA. Then, he completed both infectious disease/antibiotic stewardship pharmacy fellowship and Master of Science in clinical translational sciences at University of Arizona. He is a member of the social media committees of both the Society of Infectious Diseases Pharmacists (SIDP) and the Infectious Diseases Practice and Research Network of the American College of Clinical Pharmacy, and a member of the editorial advisory board of Contagion®. He received several prestigious international awards and published in several top-ranked journals.
Pharmacotherapy Updates II
09:00 - 09:45
|Updates in diabetes management: Focus on the recent ADA recommendations|
Dr. Mohannad Alshibani | Saudi Arabia
Dr. Mohannad Alshibani | Saudi ArabiaDirector of Pharmacy Residency Program
Mohannad Alshibani, Pharm.D, BCPS Dr. Alshibani is an Assistant Professor at the Pharmacy Practice Department at King Abduaziz University in Jeddah, Saudi Arabia. He is the deputy of Pharmacy Residency program at King Abdulaziz University Hospoital in Jeddah, Saudi Arabia. Also, he is a senior Internal Medicine Clinical Pharmacist at King Abdulaziz University Hospital. Dr. Alshibani received a Doctor of Pharmacy degree from King Abdulaziz University in 2009. He completed a PGY1 Pharmacy Practice Residency at Northwest Medical Center in Tucson, Arizona in 2015 and a PGY2 Residency in Internal Medicine at Banner - University Medical Center in Tucson, Arizona in 2016. In addition, he completed a Postdoctoral Fellowship in Internal Medicine at University of Arizona in 2018. His areas of interest include internal medicine, research and academia.
09:45 - 10:30
|Atrial fibrillation management update|
Dr. Hussain T. Bakhsh, | Saudi Arabia
Dr. Hussain T. Bakhsh, | Saudi ArabiaDirector of Pharmaceutical Services
Hussain Bakhsh, PharmD, BCPS Dr. Hussain Bakhsh, Pharm.D., BCPS, is the director of the pharmaceutical services and assistant professor at The Faculty of Pharmacy, King Abdulaziz University Hospital. Dr. Bakhsh earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Emergency Medicine Specialty Residency training at The University of Arizona. Dr. Bakhsh completed a Postdoctoral Fellowship at The University of Arizona. His area of research includes: emergency medicine and toxicology. Dr. Bakhsh is a Board-Certified Pharmacotherapy Specialist. He is an active member of the American Society of Health-System Pharmacist (ASHP) and the American College of Clinical Pharmacy (ACCP).
11:00 - 11:45
|Regulatory Influence on localizing biosimilars manufacturing: A project management approach|
Dr. Musaed Alkholief | Saudi Arabia
Dr. Musaed Alkholief | Saudi ArabiaDirector of Project Management Office Assistant Professor of Pharmaceutics Department of Pharmaceutics, College of Pharmacy
Musaed Alkholief earned his Ph.D. in 2015 from Massachusetts College of Pharmacy and Health Sciences University, USA. Following his return to Saudi Arabia, he was appointed as an Assistant Professor at the College of Pharmacy, King Saud University. Currently, Dr. Alkholief is the director of the project management office (PMO) at the college. Also, Dr. Alkholief heads the Nanobiotechnology unit that carries out research in multiple areas, including his area of interest, cancer drug delivery and drug targeting.
11:45 - 12:30
|Making sense of drug shortage complexities|
Dr. Saleh Alzahrani | Saudi Arabia
Dr. Saleh Alzahrani | Saudi ArabiaSupply Chain Director
My name is Saleh Alzahrani, working as supply chain director in king Fahad Armed Forces Hospital in Jeddah, I’m holding a master degree from Leeds university in pharmaceutical engineering. My carrier has been shifted from pharmacy practices to supply chain Leadership. I’m a team leader for more than 120 members. I’ve led many projects to optimize the whole supply chain operations. Very interested in digitalization and health care transformation.
12:30 - 13:15
|The reporting of medication errors in accreditation process (challenges - improvements)|
Dr. Saleh Ayed Al Anazi | Saudi Arabia
Dr. Saleh Ayed Al Anazi | Saudi ArabiaPharmaceutical Care Services Quality Manager CBAHI Medication Management Surveyor
Manager Quality pharmaceutical care services in King Abdulaziz medical city in Riyadh, and CBAHI Medication Management Surveyor since 2014-till now, hold master degree in pharmaceutical science from king Saud university 2015, and master degree in total quality management from The Arab Academy for Science and Technology and Maritime Transport, Alexandria, Egypt 2006, Also Certified Patient Safety Officer ( CPSO ), AIHQ since April 2015, Lecturer at the College of Pharmacy, King Saud bin Abdulaziz University for Health Science with lots of Courses inpatient and medication Safety and quality. Certified CPHQ ( score (106) ) September 2016. Lean Six Sigma Yellow Belt Certified February 18th -19th, 2015, Lean Six Sigma Green Certified February 20 -22, 2015. Member in Medication Safety Program in National Guard.
Pharmacy Practice III
09:00 - 09:45
|Community pharmacy in GCC: Current practices and future needed directions|
Dr. Abdulaziz M. Alhossan | Saudi Arabia
Dr. Abdulaziz M. Alhossan | Saudi ArabiaDirector, Corporate Pharmacy Services
Dr. Alhossan is an assistant professor of clinical pharmacy at King Saud University (KSU) and an ambulatory care clinical pharmacist at KSU medical city. He is the director of corporate pharmacy services and the chairman of the department of clinical pharmacy and the director of community pharmacy unit at the College of Pharmacy. Dr. Alhossan received a bachelor of pharmaceutical sciences degree from King Saud University and a doctor of pharmacy degree from MCPHS University, USA. He completed his PGY1 ambulatory care-focused pharmacy residency and at The University of Arizona (UA) Medical Center-El Rio Healthcare, and completed his ambulatory care fellowship program at the Center for Health Outcomes and PharmacoEconomic Research (HOPE) at the College of Pharmacy in The University of Arizona. He also completed a master of public health degree from the School of Public Health, UA. Dr. Alhossan is board certified as Pharmacotherapy Specialist (BCPS) from the board of pharmaceutical specialties (BPS) in the US and director for several committees. Dr. Alhossan’s areas of interest include ambulatory care, community pharmacy, and academia.
09:45 - 10:30
|Constructing strategies in building medications safety culture|
Dr. Mohammed Alshennawi | Saudi Arabia
Dr. Mohammed Alshennawi | Saudi ArabiaGeneral Director, General Administration of Pharmaceutical Care
• Over 22 years in King Faisal Specialist hospital & Research Centre (KFSHRC) – Riyadh, Saudi Arabia • Expertise in operations; general management; staff management; human resources; organizational planning and design; monitoring and statistical analysis Mohammed Alshennawi has extensive experience on the operations/planning/management side of pharmaceutical care. His 22 years of experience in one of the largest and very well-known organization like KFSHRC gave him the ability to improve and build himself as well as the complete opportunity to perform and participate in many of performance improvements projects and changes that resulted in a great impact on KFSHRC customer satisfaction. Mohammed also has a great achievements in outside his organization, he created and chaired the Saudi club for narcotic and controlled medications pharmacists since 2008 until now, which is one of the most active clubs under the Saudi Pharmaceutical Society (SPS). • Skills for Healthcare Organizations: Performance Improvement Assistance Leadership Education and Skill Building Organizational and Departmental Planning and Design Team building and facilitation Pharmaceutical human resource Management Organizational and Departmental Problem-solving and Decision-making • Education: Bachelor in Pharmaceutical Sciences, King Saud University, Riyadh, Saudi Arabia Master in Business Administration, Alfaisal University, Riyadh, Saudi Arabia
Research Advancement and Development II
11:00 - 11:45
|Utilizing artificial intelligence in drug design and discovery R&D: Challenges and benefits|
Dr. Ahmed Alaofi | Saudi Arabia
Dr. Ahmed Alaofi | Saudi ArabiaAssistant professor of Pharmaceutical Biotechnology Depart. of Pharmaceutics, College of Pharmacy
Dr. Ahmed Alaofi joined Pharmaceutical Chemistry Department, University of Kansas, USA in 2010. He worked as a graduate research assistant under support of NIH Biotechnology program in which he earned his MSc. degree in 2012 and his PhD in 2016 from the same department at the University of Kansas, Lawrence, KS, USA. At that time Dr. Ahmed worked on developing and designing biological and synthetic peptides to enhance treatment of brain diseases. In 2016 he was appointed as assistant professor of Pharmaceutical Biotechnology at Pharmaceutics Department, College of Pharmacy, King Saud University. Currently, his research interests focus on studying the effect of conformations and dynamic of therapeutic proteins, monoclonal antibodies, and potential viral particles to their activity, affinity and stability using dynamic techniques such as NMR, computer programs (MD Simulations), and others. In addition, his research area includes developing and designing synthetic peptides and therapeutic proteins as well as physical and chemical characterization studies for potential proteins. Dr. Ahmed is a visiting scholar for Molecular Bioscience Department at the University of Kansas, Lawrence, KS USA since 2017. Dr. Ahmed is a joint member at the National Biotechnology Center at King Abdulaziz City for Science and Technology (KACST) in infectious diseases program.
11:45 - 12:30
|Implementation of pharmacogenetics in drug dosing|
Dr. Fatemah Alherz | Saudi Arabia
Dr. Fatemah Alherz | Saudi ArabiaAssistant Professor of Pharmacology and Experimental Therapeutics College of Pharmacy
Fatemah Alherz is an assistant professor of pharmacology at Almaarefa University, Riyadh, Saudi Arabia since August 2019. She holds a Ph.D. in Experimental Therapeutics from Toledo University, Toledo, USA and a B.S. in pharmaceutical sciences from King Saud University. She is also a member of the research and quality committee of Almaarefa University. She worked at King Saud University as a postdoctoral researcher for eight months. She published several papers in genetic polymorphisms of sulfotransferase enzymes. Her research interest is studying the impact of single nucleotide genetic polymorphism on the enzymatic activity of sulfotransferase enzymes.
12:30 - 13:15
|Perspective vision: New pharmacological agents in the treatment of Alzheimer’s disease (AD)|
Dr. Ahmed H. Bu Shafia | Saudi Arabia
Dr. Ahmed H. Bu Shafia | Saudi ArabiaPharmacy Director, Pharmaceutical Care Department
Ahmed Hassan Bu Shafia is a pharmacy graduate who received his Pharm.D degree from the College of Clinical Pharmacy at King Faisal University in Al-Ahsa, Saudi Arabia in 2010. And his Master's degree in Pharmacology and Toxicology from The Arnold & Marie Schwartz College of Pharmacy and Health Sciences at Long Island University in Brooklyn, New York, the United States of America in 2015. Ahmed worked for a year as a hospital pharmacist at King Fahad Hospital in Al-Hofuf, Al-Ahsa. He is currently working as a pharmacy director, pharmacy quality coordinator, medication safety officer, and medication counseling clinic provider at Al-Omran General Hospital in Al-Ahsa. Ahmed is also the Pharmacy Therapeutics Committee Coordinator and involved as a member in a number of committees such as the Infection Control, Quality, and CPR Committees in the later hospital. And being a member of Rho Chi Society since 2014. His interest is in neuropharmacology especially in the field of neurodegenerative diseases as the Alzheimer's disease.
Pharmacy Practice I
11:00 - 11:45
|What should pharmacists know about new CBAHI medication management Standards 2020|
Dr. Abdullatif S. Alokifi | Saudi Arabia
Dr. Abdullatif S. Alokifi | Saudi ArabiaQuality and Accreditation Advisor Director of Strategic Planning and Administration Quality and Patient Safety General Directorate
Dr. Abdullatif Alokifi is the Director of Strategic Planning and Operation in General Directorate of Quality and Patient Safety at Saudi Ministry of Health. He is the General Secretary of Saudi Pharmaceutical Society. He was the CEO of Aljazeera Hospital. He used to be the Quality Director of Alhammadi Hospital. He was the Assistant Head, Ambulatory Healthcare Center Department at CBAHI. He was the Associate Executive Director for Ancillary Services at King Abdullah Bin Abdulaziz University Hospital (KAAUH) and the Pharmacy Director belong to Princess Nora University (PNU). He was also the Director of Pharmacy and A/Head of Continuous Professional Development at Riyadh Care Hospital (RCH), Riyadh. He is working as Pharmacy Surveyor at Saudi Center for Accreditation of Healthcare Institutions (CBAHI) since 2010. He has activities as a Clinical Associated Professor for training of PharmD students in cooperation with Pharmacy College, King Saud University and as a Clinical Associated Instructor at Riyadh College for Dentistry and Pharmacy for Bachelor and Master Candidates. He has a lot of participations in pharmacy management, medication safety, quality and career development. Dr. Alokifi is distinguished speaker nationally and international. He got many award as best pharmacist and best preceptor from KSU and DUPHAT pharmacy international conference in Dubai. Dr. Alokifi got his bachelor’s degree in pharmacy 2000 from KSU, Pharmacy College and his Master’s Degree 2007 in Management and Hospital Administration. He conducted many projects and improvement initiatives in shape the good pharmacy practice using the current updated quality tools.
11:45 - 12:30
|Reasons for and against prescribing pharmacist|
Dr. Sukainah Al Alshaikh | Saudi Arabia
Dr. Sukainah Al Alshaikh | Saudi ArabiaHead of Pharmacy Department Assistant Professor of Clinical Pharmacy
Dr. Sukainah Al Alshaikh is a researcher on cerebrovascular disorders with a particular focus on stroke prevention. She has obtained a Bachelor in Pharmaceutical Sciences from King Saud University then got her MSc in Clinical Pharmacy from the University of Strathclyde and obtained a PhD in Cardiovascular Sciences from the University of Glasgow in Scotland, the UK. Dr. Sukainah has presented her work in International Conferences in the United Kingdom, United States, France, Turkey and the United Arab Emirates. She is currently the Head of Pharmacy Department & Assistant Professor of Clinical Pharmacy at Mohammed Al-mana College for Medical Sciences in AlKhobar, Saudi Arabia.
12:30 - 13:15
|Fully automated forensic routine cried blood spot screening for workplace testing|
Dr. Maha K. AlMazroua | Saudi Arabia
Dr. Maha K. AlMazroua | Saudi ArabiaDirector, The Regional Poison Control Center,
Director pf the regional poison control center, Eastern Region, MOH, KSA Chief of Eastern Provence Pharmacist Club (EPPC), Saudi Pharmaceutical Society SPS since 2018 PharmD, MSc Toxicology & Forensic Sciences. PhD in Quality Management, Certified Project Manager (PME), Trainor of Trainers (TOT), KPI Diploma. Consultant at WHO in Lead (Pb) poisoning prevention and management guidelines chapter since 2011 & at National Committee of Narcotic Control (NCNC) since 2009. Published more than 25 research articles and awarded the best research award on the year 2016 from the international journal of Pharmacology & Toxicology and from the 8th world congress on Toxicology & Pharmacology held in Dubai during 2017. Member in many national & International Societies Awarded the governmental e-services best prize for the ELECTRONIC ACHEVEMENT on 2010 from YESSER an e-government Program & the best electronic prize in health care sector all over KSA from WORLD SUMMIT AWARD (WSA2018)
Pharmacy Practice II
09:00 - 09:45
|Neonatal dosage and practical considerations|
Dr. Thuraya N. Bumozah, | Saudi Arabia
Dr. Thuraya N. Bumozah, | Saudi ArabiaDirector of Training & Academic affairs Administration Deputy Director of the Pharmacy Department PICU Clinical Pharmacist Department of Pharmacy
Thuraya bumozah is a clinical pharmacist at the Maternity and children hospital (MCH), Alhasa-KSA. Dr.Thuraya earned her Bachelor’s degree in Pharmaceutical Sciences with honors from King Saud University in 2004 and her Master of Clinical Pharmacy from College of Pharmacy, The University of Queensland, Australia in 2010. Dr.Thuraya has more than 14 years’ experience working at Ministry Of Heath as hospital pharmacist; seven years of them as a clinical pharmacist in the Pediatric intensive care unit. In December 2012 she was appointed to be the Chairwoman of scientific Committee in ALhasa Pharmacy Club (APC)-Saudi Pharmaceutical Society (SPS). Thuraya participated in a large number of local scientific meetings as a speaker or organizer. She coordinated and supervised clinical pharmacy students' training programs at the hospitals where she participated in the preparation of continuing educational program, for pharmacy staff, and staff development and was appointed with several administrative pharmacy positions as a supervisor. Other areas of interest include quality improvement and medication safety.
09:45 - 10:30
|How to improve the clinical performance of pharmacy graduates?|
Dr. Mona A. Almanasef | Saudi Arabia
Dr. Mona A. Almanasef | Saudi ArabiaAssistant Professor of Clinical Pharmacy Department of Clinical Pharmacy College of Pharmacy
Mona Almanasef is an assistant professor in the Clinical Pharmacy Department at King Khalid University, Saudi Arabia. She undertook her first degree in pharmaceutical sciences at King Saud University in Saudi Arabia (2009). She completed her master’s degree in Clinical Pharmacy, International Practice and Policy at UCL School of Pharmacy in 2012 followed by a PhD in Pharmacy Practice and Policy in January 2018. Her doctoral research looked at the feasibility, acceptability and effectiveness of the “flipped classroom” instructional model on MPharm students in two pharmacy schools in the UK. Dr. Mona is an Associate Fellow of the Higher Education Academy in the UK. Her research interests include pharmacy education and active learning methods.
Research Advancement and Development I
11:00 - 11:45
|Reverse-engineering the brand drug business: The good, the bad, and the ugly!|
Dr. Aliyah Almomen, B.Sc. Pharm., Ph.D. | Saudi Arabia
Dr. Aliyah Almomen, B.Sc. Pharm., Ph.D. | Saudi ArabiaAssistant Professor of Pharmaceutical Chemistry Department of Pharmaceutical Chemistry, College of Pharmacy
11:45 - 12:30
|Can generics substitute brands? if so, for how long?!: A regulatory perspective|
Dr. Mohammad Altamimi, B.Sc. Pharm., Ph.D. | Saudi Arabia
Dr. Mohammad Altamimi, B.Sc. Pharm., Ph.D. | Saudi ArabiaDirector of Research Center Associate Professor of Pharmaceutics Department of Pharmaceutics, College of Pharmacy
12:30 - 13:15
|Brand vs. generic medications: Are patient outcomes affected? evidence from pharmacoepidemiological studies|
Dr. Monira Alwhaibi | Saudi Arabia
Dr. Monira Alwhaibi | Saudi ArabiaAssistant Professor of Clinical Pharmacy Clinical Pharmacy Department, College of Pharmacy
Monira Alwhaibi, MS, Ph.D., is Assistant Professor at the Clinical Pharmacy Department, King Saud University. She received her Ph.D. degree in 2016 from West Virginia University, United States. Dr. Alwhaibi’s primary areas of research interests include health services research, with particular emphasis on pharmacoepidemiology, medication use, looking at issues of prevalence, drugs safety, mental health, oncology, cost-analysis of drugs in healthcare systems, and complementary and alternative medicine use. Dr.Alwhaibi had more than twenty publications on these areas. Dr.Alwhaibi is proficient in handling large healthcare data (Claims Databases, EMR /electronic health data, clinical data, etc.). Dr.Alwhaibi is also skilled in using SQL, Statistical Analysis Software (SAS), and STATA.
Pharmacotherapy Updates III
09:00 - 09:45
|Cardiovascular pharmacotherapy updates|
Dr. Ahmed Aldemerdash | Saudi Arabia
Dr. Ahmed Aldemerdash | Saudi ArabiaCardiovascular Pharmacotherapy Consultant King Saud University Medical City Assistant Professor of Clinical Pharmacy Clinical Pharmacy Department, College of Pharmacy
Dr. Aldemerdash is an assistant professor in the college of pharmacy, King Saud University (KSU), Saudi Arabia and cardiovascular pharmacotherapy pharmacy specialist in King Saud University Medical City (KSUMC) where he provides comprehensive services to the cardiac ICU teams, heart failure service and anticoagulation clinics. He also serves as the director of the pharmacy practice residency program (PGY1), Cardiology Residency Program (PGY2) at KSUMC and Pharmacy fellowship programs. Dr. Aldemerdash received a bachelor’s degree in pharmaceutical sciences from KSU and PharmD degree from MCPHS University, MA, USA. He completed his PGY1 and PGY2-Cardiovascular pharmacotherapy residencies at Brigham and Women’s Hospital, MA, USA. In addition, he completed cardiovascular pharmacotherapy fellowship in the University of North Carolina. He currently services as a board member of the Saudi Society of Clinical Pharmacy.
09:45 - 10:30
|Liver cirrhosis management updates|
Dr. Khalefa M. Al Thiab | Saudi Arabia
Dr. Khalefa M. Al Thiab | Saudi ArabiaConsultant-Clinical Pharmacy (Transplant)
Dr. Khalefa Al Thiab is a consultant clinical pharmacist specialized in Solid Organ Transplantation. Dr. Al Thiab began his career in pharmacy field as a technician pharmacist after having a diploma in pharmacy from the health institute, Riyadh. He received the Bachelor of Science degree in Pharmacy from the college of pharmacy at King Saudi university. After practicing as a hospital pharmacist at King Abdulaziz Medical City Central region (KAMC-CR), he completed the three years Saudi certificate in clinical pharmacy program under the umbrella of the Saudi Commission of Health Specialties. Currently he is covering solid organ transplant & hepatology wards at KAMC-CR, and he has a joint faculty appointment with the King Saud bin Abdulaziz University for Health Sciences, College of Pharmacy.
Research Advancement and Development III
11:00 - 11:45
|Oncolytic viruses: A promising strategy for cancer immunotherapy|
Dr. Almohanad Alkayyal | Saudi Arabia
Dr. Almohanad Alkayyal | Saudi ArabiaAssistant Professor of Medical Virology, Faculty of Applied Medical Sciences
Dr. Almohanad possess expertise in translational research, specifically, biologics development for cancer immunotherapy with extensive experience in animal modeling to study and evaluate preclinical efficacy as well as immunological responses to novel anticancer agents. He has gained extensive experience in oncolytic virus engineering as well as viral-host interactions.Has a great knowledge in the understating of the conduction/design of the clinical trials as well as the pre-clinical and the non-clinical evaluation of potential drug(s). My research program focuses on development of next- generation oncolytic cancer vaccines to effectively treat cancers.
11:45 - 12:30
|Gene therapy: advances, challenges and perspectives|
Dr. Ahmad Mahmoud | Saudi Arabia
Dr. Ahmad Mahmoud | Saudi ArabiaHead of the Science and Technology Unit
Summary : My long-term research interests focus on the development and improvement of immunotherapeutic strategies, including oncolytic viruses, gene therapy, and immune checkpoint inhibitors, for the treatment of several cancers and diseases. Experience: ● Head of the Science and Technology Unit at Taibah University, (2019 – Present) ● Assistant to the Vice Dean for Graduate Studies and Scientific Research, College of Applied Medical Sciences, Taibah University, (2019 – Present) ● Assistant to the Head of Department of Medical Sciences, College of Applied Medical Sciences, Taibah University, (2019 – Present) ● Harvard Medical School Faculty Member (part-time lecturer), Boston, MA, USA. (2018 – 2019) ● Assistant professor, Taibah University, (2018 – Present) ● Scientific Advisor, VOIRx ltd, Riyadh, Saudi Arabia. (2018 – Present)
12:30 - 13:15
|Vaccines instability; mechanism, analysis, and formulation strategies|
Prof. Mohammad A. Alsenaidy, M.Sc., Ph.D. | Saudi Arabia
Prof. Mohammad A. Alsenaidy, M.Sc., Ph.D. | Saudi ArabiaChairman, Department of Pharmaceutics Associate Professor of Pharmaceutical Biotechnology Department of Pharmaceutics, College of Pharmacy